The impact of antithrombin III supplementation on prognosis during extracorporeal membrane oxygenation: a systematic review and meta-analysis
Objective To systematically evaluate the impact of antithrombin III (AT III) supplementation on the prognosis of patients undergoing extracorporeal membrane oxygenation (ECMO).Materials and methods A comprehensive literature search was conducted in PubMed, Web of Science, Embase, and the Cochrane Li...
Saved in:
Main Authors: | Ya-Ting Zeng, Yi-Nan Liu, Zi-Han Chen, Qiang Chen, Kai-Peng Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2542439 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation)
by: S. V. Zhuravel, et al.
Published: (2022-01-01) -
Management of antithrombin III deficiency in pregnancy: a representative case and a literature review
by: S. V. Akinshina, et al.
Published: (2021-09-01) -
Comparative study of chromatographic properties of affinity resins in respect of protein of antithrombin III
by: М. А. Аzhigirova, et al.
Published: (2010-04-01) -
Antithrombin III treatment for portal vein thrombosis after living donor liver transplantation: a case report
by: Yuta Hirata, et al.
Published: (2020-07-01) -
Supplementation therapy with Antithrombin Drugs in the Combined Treatment of Sepsis
by: I. V. Redkin, et al.
Published: (2019-11-01)